MedTrace Logo

Persistent Postpartum Cardiovascular Dysfunction in Patients With Preeclampsia

NCT04063397 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 27

Last updated 2024-01-10

No results posted yet for this study

Summary

The investigators plan to enroll women with PE prospectively to evaluate incremental cardiovascular risk in those who have PE with severe features. This study includes detailed echocardiographic evaluation at several time points. With the current proposal, the investigators aim to collect blood to evaluate several biomarkers to determine if there is a correlation with short and medium-term cardiovascular risk. This opens the door to earlier detection, treatment and improved cardiovascular outcomes.

Conditions

  • Preeclampsia Severe or Mild
  • Cardiac Complication

Interventions

DIAGNOSTIC_TEST

Echocardiogram

Serial echocardiograms will be done on all patients pre-delivery, and at 3-6 months

DIAGNOSTIC_TEST

Blood draw

Serial blood draws at same time points as echocardiograms for biomarker levels

Sponsors & Collaborators

  • Roche Diagnostics GmbH

    collaborator INDUSTRY

  • Ohio State University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2019-08-19
Primary Completion
2023-01-30
Completion
2023-12-14

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04063397 on ClinicalTrials.gov